Table 2 Correlations of EPC frequencies in patients with JIA and cardiovascular diseases development risk factors
|  | Percentage of CD34 + CD309+ cells | ||
|---|---|---|---|
Variable | n | rho | p |
BMI | 25 | −0.381 | 0.061 |
SDS-BMI | 25 | −0.223 | 0.283 |
SBP | 25 | −0.231 | 0.266 |
DBP | 25 | −0.257 | 0.216 |
FMD | 25 | 0.329 | 0.108 |
IMT | 25 | −0.260 | 0.210 |
Glucose | 25 | 0.005 | 0.983 |
Insulin | 25 | −0.472 | 0.017 |
HOMA IR | 25 | −0.458 | 0.021 |
Triglicerides | 25 | −0.438 | 0.029 |
Total cholesterol | 25 | −0.267 | 0.196 |
LDL-cholesterol | 25 | 0.301 | 0.144 |
HDL-cholesterol | 25 | 0.003 | 0.990 |
hsCRP | 25 | −0.210 | 0.313 |
Fractalkine | 25 | −0.031 | 0.884 |
Adiponectin | 25 | 0.145 | 0.488 |
VE-kadherin | 25 | −0.045 | 0.829 |
sICAM-1 | 25 | −0.148 | 0.481 |
sVCAM-1 | 25 | −0.157 | 0.454 |
sE-selectin | 25 | 0.009 | 0.965 |
MMP-2 | 25 | 0.140 | 0.505 |
MMP-9 | 25 | 0.135 | 0.519 |
TIMP-1 | 25 | 0.126 | 0.548 |
OSP | 25 | 0.159 | 0.447 |
TNF-α | 25 | −0.446 | 0.026 |
IL-18 | 25 | −0.364 | 0.074 |
IL-6 | 25 | −0.184 | 0.380 |